Clinical Trials Browser

Phase 3 × INDUSTRY × naloxegol × Clear all

NCT01395524 2017-02-23

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase 3 Completed

302 enrolled 13 charts

Opioid-Induced Constipation

NCT01323790 2015-06-02

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase 3 Completed

700 enrolled 25 charts

Opioid-Induced Constipation

NCT01309841 2015-06-01

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase 3 Completed

652 enrolled 25 charts

Opioid-Induced Constipation

NCT01384292 2015-06-01

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

Phase 3 Terminated

14 enrolled 7 charts

Cancer Pain, Opioid-Induced Constipation

NCT01336205 2014-10-20

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Phase 3 Completed

844 enrolled 10 charts

Opioid-Induced Constipation